Stock Price
1,513.00
Daily Change
11.35 0.76%
Monthly
10.62%
Yearly
26.96%
Q2 Forecast
1,478.96

Aurobindo Pharma reported INR39.46B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Cipla INR 26.32B 2.79B Mar/2026
Divis Laboratories Ltd INR 10.63B 1.23B Dec/2025
Dr.Reddys Laboratories INR 37.7B 1.54B Mar/2026
Hindustan Unilever INR 84.79B 1.51B Mar/2026
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
UPL INR 110.38B 43.65B Mar/2026